Gastroretentive drug delivery systems for the treatment of Helicobacter pylori.
Authors:
- 28 July 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (28) , 9321-9
Abstract
Helicobacter pylori (H. pylori) is one of the most common pathogenic bacterial infections and is found in the stomachs of approximately half of the world's population. It is the primary known cause of gastritis, gastroduodenal ulcer disease and gastric cancer. However, combined drug therapy as the general treatment in the clinic, the rise of antibiotic-resistant bacteria, adverse reactions and poor patient compliance are major obstacles to the eradication of H. pylori. Oral site-specific drug delivery systems that could increase the longevity of the treatment agent at the target site might improve the therapeutic effect and avoid side effects. Gastroretentive drug delivery systems potentially prolong the gastric retention time and controlled/sustained release of a drug, thereby increasing the concentration of the drug at the application site, potentially improving its bioavailability and reducing the necessary dosage. Recommended gastroretentive drug delivery systems for enhancing local drug delivery include floating systems, bioadhesive systems and expandable systems. In this review, we summarize the important physiological parameters of the gastrointestinal tract that affect the gastric residence time. We then focus on various aspects useful in the development of gastroretentive drug delivery systems, including current trends and the progress of novel forms, especially with respect to their application for the treatment of H. pylori infections.Keywords
This publication has 93 references indexed in Scilit:
- Pathogenesis of Helicobacter pylori InfectionHelicobacter, 2013
- Application of liposomes in drug development – focus on gastroenterological targetsInternational Journal of Nanomedicine, 2013
- The Optimal First-Line Therapy ofHelicobacter pyloriInfection in Year 2012Gastroenterology Research and Practice, 2012
- Epidemiology of Helicobacter pylori Infection and Public Health ImplicationsHelicobacter, 2011
- Effect of meal volume and calorie load on postprandial gastric function and emptying: studies under physiological conditions by combined fiber-optic pressure measurement and MRIAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment ofH. pyloriJournal of Drug Targeting, 2009
- Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews, 2006
- Helicobacter pylori: 20 years onClinical Medicine, 2002
- Liposomes in Drug DeliveryDrugs, 1993
- Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates.Journal of Pharmacobio-Dynamics, 1988